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Inhaled bronchodilators, particularly β2-agonists, are one of the
most effective therapies for rapid reversal of airway narrowing
in acute asthma. In children bronchodilators are best given
using a metered dose inhaler (MDI) with attached spacer; this
is as effective as nebulised therapy, with fewer side-effects. 1,2
However, a spacer must be used with a MDI as children are
unable to synchronise inspiration with actuation of the MDI
nor can they breath hold at the end of inspiration, particularly
when there is lower airways obstruction as occurs during an
acute asthma attack.1,2 A modified 500 ml plastic bottle spacer
has been found to be as effective as a conventional small-
volume spacer for delivery of bronchodilators in children with
acute wheezing.3-5 In contrast, a cup has been shown to be a
very poor spacer, with poor efficacy when used for giving
bronchodilators in the treatment of acute asthma.3-5
The Department of Health has recently begun to institute the
World Health Organization (WHO) programme of Integrated
Management of Childhood Illness (IMCI) nationally,6 to
promote timely diagnosis and treatment of the major illnesses
in children under 5 years of age. Such an approach has great
potential to improve child health and substantially reduce
under-5 morbidity and mortality. The South African adaptation
of these guidelines recommends use of inhaled β2-agonists via
MDI bottle-spacer and oral steroids in managing children with
recurrent wheezing; these recommendations do not currently
form part of the WHO IMCI core programme.6 However, we
note with concern the method of making and using a bottle
spacer advocated to health care providers.  The guideline states
that to make a spacer from a 500 ml plastic cold-drink bottle
one should ‘hold the top opening [of the bottle] in very hot
water to make it soft. Push the MDI into it … Then cut off the
bottom of the bottle with a sharp knife. Put tape over this cut
edge to avoid hurting the child. Place this end over the face
like a mask. When the child breathes spray 5 puffs into the
bottle.’6
These directions are incorrect and quite different from the
recommended way of adapting and using a 500 ml bottle as a
spacer. In our studies establishing the efficacy of such a spacer,
great care was taken to adapt and use the bottle in a specific
way as has been described previously.7 The following points
are of particular importance.
1. A hole should be made in the base of the bottle through
which the MDI can be inserted (Fig. 1). As the plastic base is
difficult to cut, a hole is melted by applying a heated mould of
steel wire (similar in shape and size to the end of the MDI) to
the base of the bottle.7 The MDI actuator is inserted after
removal of the mould, so as to create a tight fit. Cutting a
plastic bottle is extremely difficult. Studies have shown that the
best method of creating a hole is to use heat to melt an opening
similar in shape to the MDI canister. In addition, cutting the
bottle may create sharp, jagged edges which may hurt the child
even when covered with tape. Cutting and taping a bottle, as
recommended in the IMCI guidelines, simulates a cup, which
has been shown to be a very ineffective spacer for delivery of
bronchodilators in children.3,8,9
2.  The neck of the bottle must be held in the mouth,
simulating a mouthpiece in children older than 3 years of age
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Fig. 1. Adaptation of a 500 ml plastic bottle as a spacer –  a
wire mould is used to melt a hole in the base to fit the opening
of the MDI.
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(Fig. 2).  In younger children, a small well-fitting facemask can
be attached to the neck of a modified bottle to enable use in
those who are too young to use a mouthpiece. This ensures
that a substantial amount of aerosol is not lost to the
environment but rather delivered to the airways. The neck of
the bottle should not be deformed to try and fit the MDI
canister as recommended in the guidelines.
3.  A firm seal between the child’s mouth and the
mouthpiece of the spacer must be made to minimise aerosol
leakage; if an attached face mask is used this should fit tightly
on the face over the child’s nose and mouth. The way in which
the guidelines recommend cutting the bottle and placing tape
around the edges would result in substantial aerosol leakage
around the face, with little delivery to the lungs.8,9
4.  Only 1 puff should be fired into the spacer at a time. As
has been shown, multiple actuations of the MDI decrease the
amount of drug available, therefore drug delivery should be
optimised by actuating the canister every few breaths until the
desired dose of medication has been given.10 Therefore 5 puffs
should not be given at once, rather 1 or 2 puffs should be given
every 10 seconds.
5. The MDI canister should be shaken before use. If the
canister is not shaken first no active drug may be delivered to
the child, only carrier. There is no instruction in the IMCI
guidelines indicating that the canister should be shaken before
use.
Although a homemade bottle spacer seems simple to make
and use, this is potentially deceptive. Patients, caregivers and
health care professionals must be educated as to the optimal
way in which an MDI spacer should be made and used.
Studies3,8,9 have demonstrated the efficacy of a 500 ml bottle
when adapted and used in the correct way.  A 500 ml plastic
cold-drink bottle (modified as per published recom-
mendations7) and conventional spacer have been shown to
produce equivalent aerosol deposition in the lungs;8,9 however,
pulmonary deposition obtained with a cup was found to be
only approximately one-fifth of that achieved using a
conventional spacer.8 Furthermore, clinical studies3,5 of children
with acute asthma confirm the utility of the 500 ml cold-drink
bottle and the poor efficacy of the cup as a spacer, especially in
patients with moderate or severe airway obstruction.  The poor
efficacy of a cup is most likely due to loss of aerosol around the
edges of the cup where it fits onto the face.8,9 Use of a bottle as
recommended in the South African IMCI guidelines, with the
bottom cut off to act as a facemask, simulates a cup and would
result in substantial loss of aerosol around the face, with little
or no drug delivered to the lower airways. This would be a
completely ineffective way of administering bronchodilators.
The current recommendations for delivery of bronchodilators
as contained in the South African IMCI guidelines6 are
dangerous and to be discouraged. If we are to use a homemade
spacer then we should recommend modification and use of a
500 ml bottle, as has been demonstrated to work effectively in
carefully conducted and published trials.3,5,8,9 It is ironic that
such recommendations should be included in international
guidelines, but not in the current IMCI South African
guidelines, despite a large amount of research on homemade
spacers having been done in South Africa. 
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Fig. 2. Correct use of a modified 500 ml plastic cold-drink bottle as a
spacer. The neck of a bottle is held in the mouth while an MDI is fitted
tightly into a hole in the base of the bottle.
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